Skip to main content
Sunday
December 01, 2024
Sign In
Subscribe
Home
Epaper
Economy
Aviation
Banking
Bazaar
Budget
Industry
NBR
RMG
Corporates
Stocks
Analysis
Videos
Podcast
World+Biz
Features
Book Review
Brands
Earth
Explorer
Food
Habitat
In Focus
Luxury
Mode
Panorama
Pursuit
Wheels
Subscribe
Epaper
GOVT. Ad
More
Sports
TBS Graduates
Thoughts
Splash
Bangladesh
Supplement
Infograph
Archive
Gallery
Long Read
Interviews
Offbeat
Tech
Magazine
Climate Change
Health
Cartoons
বাংলা
SUNDAY,
DECEMBER 01, 2024
omicron
Coronavirus chronicle
Covid's new Omicron sub-lineages can dodge immunity from past infection, study says
Analysis
Demand for Pfizer's Covid pills lags around the world
Coronavirus chronicle
Omicron-specific Sinopharm, Sinovac Covid vaccine candidates cleared for clinical trial
China
China's health system faces raft of challenges as Omicron hits
Coronavirus chronicle
XE variant of Covid-19 in India: What are the symptoms of new mutation
Coronavirus chronicle
India reports first case of Covid variant XE in Mumbai
Coronavirus chronicle
A third of US Covid now caused by Omicron BA.2 as overall cases fall
Coronavirus chronicle
Nearly 30m under lockdown in China as Covid surges
World+Biz
New Zealand's Ardern signals mandates will ease after Omicron peaks
Coronavirus chronicle
Pfizer and BioNTech Omicron-targeted vaccine delayed - BioNTech CEO
USA
US officials prepare for pandemic's next phase as Omicron wanes
Coronavirus chronicle
Moderna eyes Covid booster by August, not clear yet if Omicron-specific needed
Coronavirus chronicle
Prior Covid offers less protection vs Omicron; mRNA booster shot efficacy declines within months
Show More